Abstract: The present disclosure discloses a display driving method, a display driver chip and a liquid crystal display device. The display driving method includes: within a display duration of a first bit-plane data, controlling the display device to display the first bit-plane data; when a loading duration of a single bit-plane data is longer than the display duration of the first bit-plane data, after completing the display of the first bit-plane data, controlling a pixel liquid crystal layer corresponding to the first bit-plane data in the display device to return to a target state, and completing loading of a second bit-plane data while maintaining the pixel liquid crystal layer corresponding to the first bit-plane data in the target state. Based on the above method, the cost of data driving can be effectively reduced, and the display effect of the liquid crystal display device can be improved.

Abstract: The present disclosure discloses a display driving method, a display driver chip and a liquid crystal display device. The display driving method includes: within a display duration of a first bit-plane data, controlling the display device to display the first bit-plane data; when a loading duration of a single bit-plane data is longer than the display duration of the first bit-plane data, after completing the display of the first bit-plane data, controlling a pixel liquid crystal layer corresponding to the first bit-plane data in the display device to return to a target state, and completing loading of a second bit-plane data while maintaining the pixel liquid crystal layer corresponding to the first bit-plane data in the target state. Based on the above method, the cost of data driving can be effectively reduced, and the display effect of the liquid crystal display device can be improved.

Abstract: A display control circuit applies to a LCoS panel including pixel units and a substrate. The display control circuit includes a pixel memory array circuit and a driving circuit. The pixel memory array circuit includes pixel memory units. A projection of the pixel memory array circuit on the substrate is in a projection of the pixel units on the substrate. The driving circuit includes a row driving circuit and a column driving circuit. A projection of the driving circuit on the substrate is outside the projection of the pixel units on the substrate. The driving circuit provides a modulation signal and pixel data. The pixel memory array circuit modulates the pixel data by the modulation signal to provide a pixel display voltage to each of the pixel units.

Abstract: A display control circuit applies to a LCoS panel including pixel units and a substrate. The display control circuit includes a pixel memory array circuit and a driving circuit. The pixel memory array circuit includes pixel memory units. A projection of the pixel memory array circuit on the substrate is in a projection of the pixel units on the substrate. The driving circuit includes a row driving circuit and a column driving circuit. A projection of the driving circuit on the substrate is outside the projection of the pixel units on the substrate. The driving circuit provides a modulation signal and pixel data. The pixel memory array circuit modulates the pixel data by the modulation signal to provide a pixel display voltage to each of the pixel units.

Abstract: A method for utilizing multi-tone identification and an audio apparatus utilizing the same are provided. The audio apparatus includes a microphone, a tone generator, a modulator and an amplifier. The microphone is configured to generate an audio signal. The tone generator is configured to generate a set of tones which represents a level of service, wherein the level of service indicates a service provided to the audio signal. The modulator, coupled to the microphone and the tone generator, is configured to modulate the audio signal with the set of tone to generate a modulated signal. The amplifier, coupled to the modulator, is configured to amplifying the modulated signal.

Abstract: Provided are electricity generating bicycle wheel assemblies configured to generate electrical power. In certain embodiments, an electricity generating bicycle wheel assembly includes a hub, and an axle protruding through and rotatably attached to the hub, such that the axle is configured to rigidly attach to a bicycle frame on each side of the hub. The assembly also includes an electrical generator positioned within the hub and rigidly attached to the axle. The electrical generator includes a generator axle rotatably coupled to the hub such that rotation of the hub with respect to the axle facilitates rotation of the generator axle with respect to the electrical generator.

Abstract: A device for sensing positions of a rotating wheel comprises a rotating wheel with a symmetrical weight distribution, with the rotating wheel being rigidly attached to an axle; a stationary plate coaxial with the rotating wheel, the stationary plate being free to rotate about the axle and having an asymmetrical weight distribution to keep the stationary plate stationary due to the forces of gravity; and a position sensor to sense positions of the rotating wheel.

Abstract: The invention relates to phenyl-1,2,4-oxadiazolone derivatives with phenyl group and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. What are described are compounds of the formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.

Abstract: The present invention comprises phenyl-[1,2,4]-oxadiazol-5-one derivatives of the general formula I: wherein the R1-R10 and B, U, V, W, X, Y and Z substituents are defined herein. The claimed invention also comprises the compounds isomers and their physiologically acceptable salts as well as processes for their preparation. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.

Abstract: The inventive compounds of the present invention are comprised of phenyl and pyridinyl-1,2,4-oxadiazolone derivatives and their physiologically acceptable salts and functional derivatives that are shown to provide peroxisome proliferator activator receptor (PPARdelta) agonist activity. The compounds of the present invention are comprised of the formula: wherein the substituents R1-R5 and R7-R10 are defined herein. The compounds are therapeutically effective in the regulation and modulation of lipid and carbohydrate metabolism in mammals and are thus suitable for the treatment of diseases such as type-2 diabetes, atherosclerosis, cardiovascular disorders and the like.

Abstract: The present invention relates to derivatives of 2-aminothiazoles and 2-aminooxazoles in all its stereoisomeric forms, enantiomeric forms and mixtures in any ratio, and its physiologically acceptable salts and tautomeric forms showing peroxisome proliferators activator receptor (PPAR) delta agonist activity. These compounds are compounds of the formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.

Abstract: An air-inflated mattress, comprising a top layer, an outer shroud band, a plurality of anchor separators and a bottom layer, wherein said shroud band connects the top and bottom layers together to form an inflatable bladder. A middle layer below said top layer is partially sealed to the top layer to form a plurality of sealed or half-sealed cavities, in which some or all of said cavities are in fluid communication with the inflatable bladder, via a plurality of air vents in the middle layer, creating air-pockets arrayed on the top surface of the air mattress.

Abstract: The invention relates to phenyl-1,2,4-oxadiazolone derivatives with phenyl group and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. What are described are compounds of the formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.

Abstract: A double air-inflated mattress having an upper chamber and a lower chamber, the upper chamber having a top layer, an outer shroud band, a plurality of anchor separators and a bottom layer, the outer shroud band connecting the top and bottom layers to form an inflatable bladder; a middle layer below said top layer partially sealed to the top layer to form a plurality of sealed or half-sealed cavities, in which some or all of said cavities are in fluid communication with the inflatable bladder, the lower chamber having a top layer, an outer shroud band, a plurality of anchor separators and a bottom layer, said outer shroud band connecting the top and bottom layers to form an inflatable bladder.

Abstract: The present invention comprises phenyl and pyridinyl 1,2,4-oxadiazolone compounds their physiologically acceptable salts and physiologically functional derivatives that exhibit peroxisome proliferator activator receptor (PPAR) delta agonist activity. Also described and claimed are processes for their preparation and their use as pharmaceuticals. These are compounds of formula I, in which the R-group substituents are defined herein. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and de-myelinating and other neurodegenerative disorders of the central and peripheral nervous system.

Abstract: The present invention comprises phenyl-[1,2,4]-oxadiazol-5-one derivatives of the general formula I: wherein the R1-R10 and B, U, V, W, X, Y and Z substituents are defined herein. The claimed invention also comprises the compounds isomers and their physiologically acceptable salts as well as processes for their preparation. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.

Abstract: The inventive compounds of the present invention are comprised of phenyl and pyridinyl-1,2,4-oxadiazolone derivatives and their physiologically acceptable salts and functional derivatives that are shown to provide peroxisome proliferator activator receptor (PPARdelta) agonist activity. The compounds of the present invention are comprised of the formula: wherein the substituents R1-R5 and R7-R10 are defined herein. The compounds are therapeutically effective in the regulation and modulation of lipid and carbohydrate metabolism in mammals and are thus suitable for the treatment of diseases such as type-2 diabetes, atherosclerosis, cardiovascular disorders and the like.

Abstract: The present invention relates to derivatives of 2-aminothiazoles and 2-aminooxazoles in all its stereoisomeric forms, enantiomeric forms and mixtures in any ratio, and its physiologically acceptable salts and tautomeric forms showing peroxisome proliferators activator receptor (PPAR) delta agonist activity. These compounds are compounds of the formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.

Abstract: A double air-inflated mattress having an upper chamber and a lower chamber, the upper chamber having a top layer, an outer shroud band, a plurality of anchor separators and a bottom layer, the outer shroud band connecting the top and bottom layers to form an inflatable bladder; a middle layer below said top layer partially sealed to the top layer to form a plurality of sealed or half-sealed cavities, in which some or all of said cavities are in fluid communication with the inflatable bladder, the lower chamber having a top layer, an outer shroud band, a plurality of anchor separators and a bottom layer, said outer shroud band connecting the top and bottom layers to form an inflatable bladder.

Abstract: An air-inflated mattress, comprising a top layer, an outer shroud band, a plurality of anchor separators and a bottom layer, wherein said shroud band connects the top and bottom layers together to form an inflatable bladder. A middle layer below said top layer is partially sealed to the top layer to form a plurality of sealed or half-sealed cavities, in which some or all of said cavities are in fluid communication with the inflatable bladder, via a plurality of air vents in the middle layer, creating air-pockets arrayed on the top surface of the air mattress.